Soleus Capital Management’s Biodesix BDSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BDSX
ACM
TAM
BC
EIM
OM
PA
Soleus Capital Management's BDSX Position: Q2 2026 in Review
Soleus Capital Management increased its Biodesix (BDSX) stake by 41% in Q2 2026, buying an estimated $2.51M and bringing the position to 585,958 shares worth $13.2M. The position accounts for 0.46% of the portfolio, ranked #51.
Soleus Capital Management first reported a position in BDSX in Q2 2024 and has held it in 4 quarters since. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.
- Soleus Capital Management held 585,958 shares of Biodesix worth $13.2M as of Q2 2026.
- Soleus Capital Management bought 169,359 Biodesix shares in Q2 2026, an estimated $2.51M.
- Biodesix made up 0.46% of Soleus Capital Management's portfolio in Q2 2026, its #51 holding.
- Soleus Capital Management first reported a position in Biodesix in Q2 2024 and has held it in 4 quarters since.
- 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.
Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.